Notably, high expression of IRF8 and MEF2D was associated with adverse outcomes in the TCGA AML data set, although the same effect did not reach statistical significance in the BeatAML data set (Supplemental Fig. S1; The Cancer Genome Atlas Research Network 2013; Tyner et al. 2018). Here, MEF2D is linked to acute myeloid leukemia.